Results 191 to 196 of about 6,165 (196)
Some of the next articles are maybe not open access.
Human embryonal carcinoma tumor antigen, Gp200/GCTM-2, is podocalyxin
Biochemical and Biophysical Research Communications, 2003We previously characterized a peanut agglutinin-binding tumor antigen, gp200, a surface membrane glycoprotein expressed on human embryonal carcinoma, a malignant stem cell of testicular tumors. Gp200 is remarkably similar to another embryonal carcinoma antigen, GCTM-2, a cell differentiation marker that is also detected in blood of testis cancer ...
W Michael, Schopperle +2 more
openaire +2 more sources
The role of Podocalyxin in colorectal cancer
2023Abstract not currently available.
openaire +2 more sources
Erythropoietin Modulation of Podocalyxin within an Erythroblast Niche.
Blood, 2006Abstract Epo’s capacity to promote red cell production is ascribed largely to anti-apoptotic effects on erythroid progenitor pools. Via gene profiling of bone marrow- derived erythroblasts, Epo is now revealed to down-modulate chemokine receptor-4 (Cxcr4) and integrin alpha-4 (Itga4), and to selectively up-modulate the expression of ...
Don M. Wojchowski +6 more
openaire +1 more source
[A study of urinary podocalyxin in children with IgA nephropathy].
Nihon Jinzo Gakkai shi, 1995The existence of podocalyxin (PCX) in urine sediments of 30 children with IgA nephropathy was identified by positive findings of immunofluorescence testing using a monoclonal antibody (PHM-5). Three structures (cells (podocytes), casts, granules) were stained and arbitrarily scored according to their numbers and intensity of fluorescence.
openaire +1 more source
Podocalyxin expression in undifferentiated thyroid carcinomas.
Journal of clinical pathology, 2015H, Yasuoka +8 more
openaire +1 more source
Podocalyxin expression in undifferentiated thyroid carcinomas: Figure 1
Journal of Clinical Pathology, 2008H Yasuoka +8 more
openaire +1 more source